Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-1B | 18.0 | 41 | |
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-1B | 19.0 | 32 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-1B | 21.0 | 33 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-1B | 15.0 | 34 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-1B | 18.0 | 50 | |
0 | IL-1B | 13.0 | 74 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 21.5 | 64 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 30.0 | 63 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 18.0 | 64 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 24.0 | 83 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 23.0 | 65 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 20.0 | 54 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 22.5 | 64 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 21.0 | 59 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 26.0 | 76 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 28.0 | 65 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 13.0 | 52 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-1B | 22.0 | 55 | |
RA2159 | 3 | IL-1B | 11.0 | 58 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL-1B | 14.0 | 54 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-1B | 12.0 | 55 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-1B | 13.0 | 65 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-1B | 13.5 | 60 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL-1B | 14.5 | 60 | ||||
RA2159 | 3 | IL-1B | 16.0 | 67 |